Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,212 | 16 | 51.9% |
| Consulting Fee | $1,125 | 1 | 48.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Varian Medical Systems, Inc. | $1,188 | 4 | $0 (2018) |
| Brainlab, Inc. | $227.82 | 1 | $0 (2020) |
| E.R. Squibb & Sons, L.L.C. | $195.47 | 2 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $176.02 | 2 | $0 (2019) |
| Genentech USA, Inc. | $149.99 | 1 | $0 (2019) |
| Seagen Inc. | $113.52 | 1 | $0 (2023) |
| GENZYME CORPORATION | $100.83 | 1 | $0 (2023) |
| PFIZER INC. | $98.65 | 1 | $0 (2024) |
| Siemens Medical Solutions USA, Inc. | $39.78 | 1 | $0 (2024) |
| Novocure Inc. | $32.04 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $138.43 | 2 | PFIZER INC. ($98.65) |
| 2023 | $214.35 | 2 | Seagen Inc. ($113.52) |
| 2022 | $16.34 | 1 | Novocure Inc. ($16.34) |
| 2021 | $107.24 | 2 | E.R. Squibb & Sons, L.L.C. ($91.54) |
| 2020 | $227.82 | 1 | Brainlab, Inc. ($227.82) |
| 2019 | $228.64 | 2 | Genentech USA, Inc. ($149.99) |
| 2018 | $1,300 | 6 | Varian Medical Systems, Inc. ($1,188) |
| 2017 | $103.93 | 1 | E.R. Squibb & Sons, L.L.C. ($103.93) |
All Payment Transactions
17 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/06/2024 | PFIZER INC. | LORBRENA (Drug) | Food and Beverage | In-kind items and services | $98.65 | General |
| Category: ONCOLOGY | ||||||
| 05/24/2024 | Siemens Medical Solutions USA, Inc. | — | Food and Beverage | In-kind items and services | $39.78 | General |
| 11/01/2023 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $100.83 | General |
| Category: Oncology | ||||||
| 05/11/2023 | Seagen Inc. | TUKYSA (Drug) | Food and Beverage | In-kind items and services | $113.52 | General |
| Category: Oncology | ||||||
| 08/18/2022 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $16.34 | General |
| Category: Oncology | ||||||
| 12/10/2021 | Novocure Inc. | Optune (Device) | Food and Beverage | Cash or cash equivalent | $15.70 | General |
| Category: Oncology | ||||||
| 05/13/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $91.54 | General |
| Category: Oncology | ||||||
| 03/06/2020 | Brainlab, Inc. | — | Food and Beverage | Cash or cash equivalent | $227.82 | General |
| Category: Surgical planning and navigation radiation treatment planning and positioning | ||||||
| 11/06/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $78.65 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2019 | Genentech USA, Inc. | Herceptin (Biological), TECENTRIQ | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: BioOncology | ||||||
| 10/29/2018 | Varian Medical Systems, Inc. | OTHER (Device) | Consulting Fee | Cash or cash equivalent | $1,125.00 | General |
| Category: Devices | ||||||
| 06/01/2018 | Varian Medical Systems, Inc. | TrueBeam (Device) | Food and Beverage | In-kind items and services | $29.21 | General |
| Category: Devices | ||||||
| 05/10/2018 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $97.37 | General |
| Category: Oncology | ||||||
| 02/22/2018 | Varian Medical Systems, Inc. | — | Food and Beverage | In-kind items and services | $26.68 | General |
| 01/22/2018 | Midatech Pharma US Inc | Gelclair (Device) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Y | ||||||
| 01/20/2018 | Varian Medical Systems, Inc. | Edge (Device) | Food and Beverage | In-kind items and services | $6.82 | General |
| Category: Devices | ||||||
| 11/02/2017 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $103.93 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 498 | 1,475 | $248,563 | $93,689 |
| 2022 | 19 | 456 | 1,245 | $204,846 | $79,282 |
| 2021 | 17 | 469 | 1,350 | $220,526 | $86,335 |
| 2020 | 19 | 571 | 1,629 | $260,384 | $100,300 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 39 | 145 | $53,317 | $23,535 | 44.1% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 18 | 240 | $22,824 | $9,173 | 40.2% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 24 | 25 | $34,340 | $8,983 | 26.2% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 40 | 138 | $26,220 | $6,980 | 26.6% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2023 | 27 | 391 | $16,305 | $6,825 | 41.9% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 46 | 46 | $9,200 | $6,592 | 71.7% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 45 | 180 | $17,965 | $5,051 | 28.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 32 | 32 | $10,900 | $4,852 | 44.5% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 21 | 22 | $15,400 | $4,241 | 27.5% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 18 | 21 | $10,324 | $4,048 | 39.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 28 | 38 | $4,940 | $2,880 | 58.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Facility | 2023 | 38 | 56 | $4,424 | $2,842 | 64.2% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 27 | 28 | $6,720 | $1,973 | 29.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $2,530 | $1,598 | 63.2% |
| 77470 | Special radiation treatment | Facility | 2023 | 14 | 14 | $4,550 | $1,279 | 28.1% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2023 | 23 | 33 | $3,630 | $1,072 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 20 | $2,000 | $1,051 | 52.6% |
| 77332 | Design and construction of simple radiation treatment device | Facility | 2023 | 28 | 35 | $2,975 | $715.11 | 24.0% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 36 | 119 | $43,756 | $19,566 | 44.7% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2022 | 29 | 404 | $16,847 | $7,063 | 41.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 44 | 44 | $14,988 | $6,719 | 44.8% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 38 | 40 | $8,000 | $5,782 | 72.3% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2022 | 36 | 109 | $20,710 | $5,684 | 27.4% |
| 77295 | 3d radiation therapy planning | Facility | 2022 | 24 | 28 | $19,600 | $5,447 | 27.8% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 14 | 140 | $13,314 | $5,409 | 40.6% |
About Dr. Thyra Endicott, MD
Dr. Thyra Endicott, MD is a Radiation Oncology healthcare provider based in Redondo Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/23/2006. The National Provider Identifier (NPI) number assigned to this provider is 1023039948.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thyra Endicott, MD has received a total of $2,337 in payments from pharmaceutical and medical device companies, with $138.43 received in 2024. These payments were reported across 17 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,212).
As a Medicare-enrolled provider, Endicott has provided services to 1,994 Medicare beneficiaries, totaling 5,699 services with total Medicare billing of $359,606. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Radiation Oncology
- Location Redondo Beach, CA
- Active Since 07/23/2006
- Last Updated 10/30/2008
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1023039948
Products in Payments
- OTHER (Device) $1,125
- IMFINZI (Drug) $176.02
- Herceptin (Biological) $149.99
- TUKYSA (Drug) $113.52
- SARCLISA (Biological) $100.83
- LORBRENA (Drug) $98.65
- OPDIVO (Biological) $91.54
- Optune (Device) $32.04
- TrueBeam (Device) $29.21
- Gelclair (Device) $14.98
- Edge (Device) $6.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.